Medical staff at Royal Papworth treat a critically ill Covid-19 patient in 2021. Photograph: Lynsey Addario/Getty Images
Dismay as UK government halts cash for world-renowned Covid programme
Despite its trials saving thousands during the pandemic, funding is being stopped for the groundbreaking UK Recovery programme
It changed the treatment of Covid-19 patients across the globe, saved thousands of lives by pinpointing cheap, effective drugs during the pandemic, and earned Britain widespread praise from international groups of scientists.
But now government support for the UK Recovery programme is to end. In a few weeks’ time, central financing for the programme will halt. The scheme will only be able to continue thanks to funding from a group of US-based philanthropists.
The move has dismayed senior scientists who say it is another worrying example of the UK’s life sciences sector being short-changed by government. “We knew Recovery had huge potential and that was realised in a very short period during Covid. But now that dream is being unrealised,” said Prof Peter Horby, one of the co-founders of Recovery.
And it is not just the value of Recovery that has been ignored as the pandemic has ended, added Horby. “Britain did some of the world’s best clinical trials, vaccine development, and genomics work, but a lot of that has just been thrown away or starved of investment. Yet we badly need to be alert to the dangers of future pandemics.”
Recovery – the Randomised Evaluation of Covid-19 Therapy – is a drug-testing programme that, at the height of the pandemic, involved thousands of doctors and nurses working with tens of thousands of Covid-19 patients in hospitals across Britain. Trials were carried out in intensive care units and wards crammed with seriously ill patients.
“In day-to-day, regular clinical medicine, it’s absolutely critical to work out the difference between what you think might work, what actually works – and what doesn’t,” said Prof Martin Landray, Recovery’s other co-founder. “Recovery did exactly that.”
The programme managed to pinpoint four effective medicines, while conclusively showing that eight overhyped drugs were not. For example, the anti-malarial drug hydroxychloroquine – widely touted by Donald Trump as a Covid-19 treatment – was found to be ineffective.
